S'abonner

Comparison of the First and Second Waves of the Coronavirus Disease 2019 Pandemic in Children and Adolescents in a Middle-Income Country: Clinical Impact Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Gamma Lineage - 06/05/22

Doi : 10.1016/j.jpeds.2022.01.001 
Eduardo A. Oliveira, MD, PhD 1, 2, , Ana Cristina Simões e Silva, PhD 1, Maria Christina L. Oliveira, PhD 1, 2, Enrico A. Colosimo, PhD 3, Robert H. Mak, MD 4, Mariana A. Vasconcelos, PhD 1, Debora M. Miranda, PhD 1, Daniella B. Martelli, PhD 5, Ludmila R. Silva, MSc 6, Clara C. Pinhati, MD 1, Hercílio Martelli-Júnior, PhD 5
1 Department of Pediatrics, Health Sciences Postgraduate Program, School of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil 
2 Visiting Scholar, Department of Pediatrics, University of California San Diego, La Jolla, CA 
3 Department of Statistics, Federal University of Minas Gerais, Belo Horizonte, Brazil 
4 Department of Pediatrics, Rady Children’s Hospital, University of California San Diego, La Jolla, CA 
5 Health Science/Primary Care Postgraduate Program, State University of Montes Claros, Montes Claros, Brazil 
6 Health Science/Postgraduate Program in Nursing, School of Nursing, Federal University of Minas Gerais, Belo Horizonte, Brazil 

Reprint requests: Eduardo A. Oliveira, MD, PhD, Federal University of Minas Gerais, R. Engenheiro Amaro Lanari 389/501, 30310-580 Belo Horizonte, MG, BrazilFederal University of Minas GeraisR. Engenheiro Amaro Lanari 389/501Belo HorizonteMG30310-580Brazil

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

Objective

To evaluate the severity and clinical outcomes of the SARS-CoV-2 gamma variant in children and adolescents hospitalized with COVID-19 in Brazil.

Study design

In this observational retrospective cohort study, we performed an analysis of all 21 591 hospitalized patients aged <20 years with confirmed SARS-CoV-2 infection registered in a national database in Brazil. The cohort was divided into 2 groups according to the predominance of SARS-CoV-2 lineages (WAVE1, n = 11 574; WAVE2, n = 10 017). The characteristics of interest were age, sex, geographic region, ethnicity, clinical presentation, and comorbidities. The primary outcome was time to death, which was evaluated by competing-risks analysis, using cumulative incidence functions. A predictive Fine and Gray competing-risks model was developed based on the WAVE1 cohort with temporal validation in the WAVE2 cohort.

Results

Compared with children and adolescents admitted during the first wave, those admitted during the second wave had significantly more hypoxemia (52.5% vs 41.1%; P < .0001) and intensive care unit admissions (28.3% vs 24.9%; P < .0001) and needed more noninvasive ventilatory support (37.3% vs 31.6%; P < .0001). In-hospital deaths and death rates were 896 (7.7%) in the first wave and 765 (7.6%) in the second wave (P = .07). The prediction model of death included age, ethnicity, region, respiratory symptoms, and comorbidities. In the validation set (WAVE2), the C statistic was 0.750 (95% CI, 0.741-0.758; P < .0001).

Conclusions

This large national study found a more severe spectrum of risk for pediatric patients with COVID-19 caused by the gamma variant. However, there was no difference regarding the probability of death between the waves.

Le texte complet de cet article est disponible en PDF.

Keywords : COVID-19, children, adolescents, gamma variant, clinical prediction model

Abbreviations : AUC, CIF, ICU, SIVEP-Gripe


Plan


 Supported by the National Council for Scientific and Technological Development (CNPq) and the Research Support Foundation of Minas Gerais (FAPEMIG). The funding organizations had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. The authors declare no conflicts of interest.


© 2022  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 244

P. 178 - mai 2022 Retour au numéro
Article précédent Article précédent
  • Anthropometric Measures Correspond with Functional Motor Outcomes in Females with Rett Syndrome
  • Kathleen J. Motil, Suzanne Geerts, Fran Annese, Jeffrey L. Neul, Tim Benke, Eric Marsh, David Lieberman, Steven A. Skinner, Daniel G. Glaze, Peter Heydemann, Arthur Beisang, Shannon Standridge, Robin Ryther, Jane B. Lane, Lloyd Edwards, Alan K. Percy
| Article suivant Article suivant
  • Examining Clinical Practice Guidelines for Male Circumcision: A Systematic Review and Critical Appraisal Using AGREE II
  • Martha Pokarowski, Jin Kyu Kim, Karen Milford, Priyank Yadav, Martin Koyle, Quenby Mahood, Joana Dos Santos, Mandy Rickard, Armando Lorenzo, Michael Chua

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.